RM del carcinoma de próstata. Una guía para empezar, intepretar e informar los estudios
Palabras clave:
carcinoma, prostata, RMResumen
Presentar como describir de forma estructurada el informe utilizando el sistema de datos PIRADS.
Revisar por qué el uso de la espectroscopia por RM en la próstata no se ha generalizado.
Descargas
Citas
Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012;22:746-757.
Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 2015;67:1112-1121.
Park SY, Jung DC, Oh YT, et al. Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers. Radiology. 2016; :151133.
PI-RADSTM Prostate Imaging and Reporting and Data System: 2015, version 2. American College of Radiology Web site. http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf. Último acceso: 10-03-16.
Vaché T, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, Rouvière O. Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology 2014; 272:446-55.
Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40.
